Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Current Assets (2010 - 2025)

Siga Technologies' (SIGA) quarterly Current Assets came in at $212.9 million in Q4 2025, down 7.87% on a YoY basis from $231.0 million in Q4 2024, and down 6.54% quarter-over-quarter from $227.7 million in Q3 2025.

Analysis

Siga Technologies (SIGA) Current Assets (2010 - 2025) Analysis & Trends

Siga Technologies (SIGA) has reported Current Assets for 16 consecutive years, with $212.9 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Current Assets fell 7.87% year-over-year to $212.9 million; the trailing twelve-month figure through Dec 2025 stood at $212.9 million (down 7.87% YoY), and the FY2025 full-year result was $212.9 million, down 7.87% from the prior year.
  • Current Assets eased to $212.9 million in Q4 2025 per SIGA's latest filing, from $227.7 million in the prior quarter.
  • Across five years, Current Assets topped out at $239.0 million in Q4 2023 and bottomed at $127.1 million in Q2 2021.
  • Historically, Current Assets has averaged $186.1 million across 5 years, with a median of $183.2 million in 2022.
  • The sharpest annual moves came in 2022 and 2023: Current Assets surged 52.71% in 2022, then fell 25.87% in 2023.
  • Over 5 years, Current Assets stood at $208.8 million in 2021, then declined by 11.0% to $185.8 million in 2022, then gained by 28.64% to $239.0 million in 2023, then retreated by 3.32% to $231.0 million in 2024, then dropped by 7.87% to $212.9 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods registered $212.9 million, $227.7 million, and $229.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 59.77 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 33.67 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 27.35 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 41.36 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 36.64 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 4.03 Bn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 6.03 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 3.48 Bn
10 Siga Technologies 220.19 Mn 65.22 Mn - 212.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 212.86 Mn
Sep 30, 2025 227.75 Mn
Jun 30, 2025 229.20 Mn
Mar 31, 2025 233.62 Mn
Dec 31, 2024 231.04 Mn
Sep 30, 2024 180.69 Mn
Jun 30, 2024 176.48 Mn
Mar 31, 2024 227.89 Mn
Dec 31, 2023 238.99 Mn
Sep 30, 2023 145.97 Mn
Jun 30, 2023 134.30 Mn
Mar 31, 2023 172.53 Mn
Dec 31, 2022 185.79 Mn
Sep 30, 2022 196.90 Mn
Jun 30, 2022 153.64 Mn
Mar 31, 2022 177.11 Mn
Dec 31, 2021 208.75 Mn
Sep 30, 2021 128.94 Mn
Jun 30, 2021 127.07 Mn
Mar 31, 2021 132.89 Mn